Key result
Conventional aortic valve replacement in patients aged 70 years or older demonstrated an overall operative mortality of 3.9%, which was lower than the expected STS-PROM mortality of 4.8%.
Why the study?
Does conventional aortic valve replacement provide durable survival and low operative mortality in elderly patients (≥70 years) with aortic stenosis?
Cohort (n=308)
No
Does conventional aortic valve replacement provide durable survival and low operative mortality in elderly patients (≥70 years) with aortic stenosis?
Conventional aortic valve replacement in patients aged 70 and older demonstrates low operative mortality and durable long-term survival, serving as a benchmark for transcatheter approaches.
Answers are grounded in this paper and cite their sources.
Supports conventional AVR in elderly patients with mortality below predictions; leaves open randomized comparisons to transcatheter approaches.
BACKGROUND: Because of the rising expectation of prolonged life in the general population and the recent recognition of undertreated aortic valve disease in the elderly, updating the available results of aortic valve surgery is imperative, especially considering the rapid evolution of the transcatheter valve implantation procedure. METHODS AND RESULTS: Between 1997 and 2010, 308 patients aged 70 years or older underwent aortic valve replacement (AVR) for aortic stenosis (AS). Short- and long-term results were analyzed and risk factors for long-term mortality were determined. Mean age was 78.5 years and 124 patients were aged 80 or older. Concomitant coronary artery bypass grafting (CABG) was performed in 46% of the cases. Mean left ventricular ejection fraction (LVEF) was 52%. Overall observed and expected operative mortality using the Society of Thoracic Surgeons-Predicted Risk of Mortality score was 3.9% and 4.8%, respectively. Overall survival rates at 1, 5, and 10 years were 88.6%, 71.6%, and 31.8%, respectively. Predictors of long-term mortality included diabetes; preoperative shock; LVEF ≤ 40%; New York Heart Association functional class III or IV; and age. CONCLUSIONS: Short- and long-term results of conventional AVR in the elderly prove it to be durable and, especially in relatively low-risk patients and patients who require concomitant CABG, operative mortality is reasonably low. Conventional AVR ± CABG remains the gold standard for elderly patients with AS.
No takes yet. Share an insight, caveat, or question.
Yamane et al. (2011) conducted a cohort in Aortic stenosis (n=308). Conventional aortic valve replacement (AVR) vs. Expected mortality (STS-PROM) was evaluated on Operative mortality (death during hospitalization or within 30 days after surgery). Conventional aortic valve replacement in patients aged 70 years or older demonstrated an overall operative mortality of 3.9%, which was lower than the expected STS-PROM mortality of 4.8%.
Synapse has enriched 10 related papers. Consider them for comparative context: